Literature DB >> 29729469

Primary Intracranial pPNET/Ewing Sarcoma: Diagnosis, Management, and Prognostic Factors Dilemma-A Systematic Review of the Literature.

Abad Cherif El Asri1, Mohamed Benzagmout2, Khalid Chakour2, Mohamed Faiz Chaoui2, Jawad Laaguili3, Hafsa Chahdi4, Miloudi Gazzaz3, Brahim El Mostarchid3.   

Abstract

BACKGROUND: Ewing sarcoma (ES) is a malignant bone tumor that is most commonly observed in the long bones, the pelvis, and the chest. Primary intracranial localization is extremely rare.
OBJECTIVE: In the aim of identifying the prognostic factors of this rare localization, we conducted a systematic review of the literature for patients with primary intracranial peripheral primitive neuroectodermal tumor/ES.
METHODS: A complete MEDLINE search was undertaken for all articles reporting data for primary intracranial peripheral primitive neuroectodermal tumor/ES. We divided the patient population into 2 groups: group I, patients who were free of disease; and group II, patients who died or had uncontrolled disease at the last available follow-up. We conducted a comparative statistical analysis of data between the 2 groups.
RESULTS: A total of 48 patients were included in the review. There were 32 patients in group I and 12 in group II. Fifty percent of tumors in group II and only 16% of tumors in group I were infratentotorial (P = 0.03). Signs of bone involvement were observed in 19% of patients in group I and 54% in group II (P = 0.03). Total removal was accomplished in 29% of patients in group I and in no patients in group II (P = 0.03). Radiotherapy was performed in 73% of patients in group II and 81% in group I (P = 0.43). Chemotherapy was administered in 36% of patients in group II and 74% in group I (P = 0.03).
CONCLUSIONS: Infratentorial localization and the presence of bone involvement were associated with poor prognosis; Surgery seems to be a predictive factor of prognosis; radiotherapy and chemotherapy must be performed whenever the tumor is not totally removed.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Dural; Ewing sarcoma; Intracranial; Management; Prognosis; pPNET

Mesh:

Year:  2018        PMID: 29729469     DOI: 10.1016/j.wneu.2018.04.164

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  7 in total

1.  Intracranial Ewing sarcoma with whole genome study.

Authors:  Jeemin Yim; Woo Seung Lee; Seung Ki Kim; Hyoung Jin Kang; Jeongmo Bae; Sung-Hye Park
Journal:  Childs Nerv Syst       Date:  2018-11-07       Impact factor: 1.475

2.  Primary intracranial extraosseous Ewing's sarcoma of the skull base in an elderly adult: illustrative case.

Authors:  Kristine Ravina; Sonora A Windermere; Qing Zhao; Adam Lerner; Michael Dyer; Urvashi Upadhyay; R Tushar Jha
Journal:  J Neurosurg Case Lessons       Date:  2022-10-17

3.  Primitive neuroectodermal tumors: a clinical and radiological analysis of six cases.

Authors:  Jiao Liu; Yue-Ling Zhao; Si-Qi Song; Zhen-Hua Li; Pei-Ling Li
Journal:  Quant Imaging Med Surg       Date:  2019-04

Review 4.  Primary and Metastatic Intracranial Ewing Sarcoma at Diagnosis: Retrospective International Study and Systematic Review.

Authors:  Lianne M Haveman; Andreas Ranft; Henk van den Berg; Stephanie Klco-Brosius; Ruth Ladenstein; Michael Paulussen; Heribert Juergens; Uta Dirksen; Johannes H M Merks
Journal:  Cancers (Basel)       Date:  2020-06-24       Impact factor: 6.639

5.  Cranial Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumors: A Retrospective Study Focused on Prognostic Factors and Long-Term Outcomes.

Authors:  Jun Chen; Ruimin Cheng; Fanfan Fan; Yifeng Zheng; Yakun Li; Yong Chen; Yu Wang
Journal:  Front Oncol       Date:  2019-10-09       Impact factor: 6.244

6.  Primary Gliosarcoma of the Cerebellum in a Young Pregnant Woman: Management Challenges and Immunohistochemical Features.

Authors:  Marco Meloni; Salvatore Serra; Giulia Bellisano; Nikolaos Syrmos; Sanjeeva Jeyaretna; Mario Ganau
Journal:  Case Rep Surg       Date:  2019-07-16

Review 7.  The spectrum of rare central nervous system (CNS) tumors with EWSR1-non-ETS fusions: experience from three pediatric institutions with review of the literature.

Authors:  Oscar Lopez-Nunez; Barbara Cafferata; Mariarita Santi; Sarangarajan Ranganathan; Thomas M Pearce; Scott M Kulich; Kelly M Bailey; Alberto Broniscer; Sabrina Rossi; Angelica Zin; MacLean P Nasrallah; Marilyn M Li; Yiming Zhong; Evelina Miele; Rita Alaggio; Lea F Surrey
Journal:  Brain Pathol       Date:  2020-11-06       Impact factor: 6.508

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.